Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
Crinó A, Schiaffini R, Ciampalini P, Suraci MC, Manfrini S, Visalli N, Matteoli MC, Patera P, Buzzetti R, Guglielmi C, Spera S, Costanza F, Fioriti E, Pitocco D, Pozzilli P; IMDIAB Group. Crinó A, et al. Among authors: guglielmi c. J Pediatr Endocrinol Metab. 2005 Aug;18(8):749-54. doi: 10.1515/jpem.2005.18.8.749. J Pediatr Endocrinol Metab. 2005. PMID: 16200840 Clinical Trial.
The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).
Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. Pitocco D, et al. Among authors: guglielmi c. Diabet Med. 2006 Aug;23(8):920-3. doi: 10.1111/j.1464-5491.2006.01921.x. Diabet Med. 2006. PMID: 16911633 Clinical Trial.
Immunomodulation for the prevention of SPIDDM and LADA.
Pozzilli P, Guglielmi C. Pozzilli P, et al. Among authors: guglielmi c. Ann N Y Acad Sci. 2006 Oct;1079:90-8. doi: 10.1196/annals.1375.012. Ann N Y Acad Sci. 2006. PMID: 17130536 Review.
Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function.
Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. Pitocco D, et al. Among authors: guglielmi c. Horm Metab Res. 2008 Jan;40(1):66-8. doi: 10.1055/s-2007-993217. Epub 2007 Dec 18. Horm Metab Res. 2008. PMID: 18085501 Clinical Trial. No abstract available.
172 results